2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists. Abstract Text:
The synthesis and SAR for a novel series of 2-alkyl-4-aryl-tetrahydro-pyrido-pyrimidines and 2-alkyl-4-aryl-tetrahydro-pyrimido-azepines is described. Representative compounds were shown to be subtype selective 5-HT(2A) antagonists. Optimal placement of a basic nitrogen relative to the pyrimidine and the presence of a 4-fluorophenyl group in the pyrimidine 4-position was found to have a profound effect on affinity and selectivity.
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists. Publishing Authors By Initials
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Bioorganic & medicinal chemistry letters
VOLUME: 18
Page Numbers: 2103-8
Journal Abbreviation: Bioorg. Med. Chem. Lett.
ISSN: 1464-3405
DAY: 30
MONTH: 01
YEAR: 2008
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9107377
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
AFFILIATION: Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA. BShirema@prdus.jnj.com <BShirema@prdus.jnj.com>
Country: England
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Bioorg Med Chem Lett
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists Related Publications